Table 1. Baseline data of patients in the treatment groups.
| Variable | Treatment Group | p- value | ||
|---|---|---|---|---|
| Probiotic group (n=16) | Antibiotic group (n=16) | Placebo group (n=15) | ||
| Age1 (years) | 46.5 ± 9.3 | 49.0 ± 7.9 | 52.8 ± 7.5 | 0.1171 |
| Gender (M/F)2 | 8 / 8 | 10 / 6 | 8 / 7 | 0.8150 |
| Smokers2 | 7 (43.8%) | 3 (18.7%) | 6 (40.0%) | 0.3440 |
| CAL (mm)3 | 3.8 ± 0.7 | 4.4 ± 0.9 | 4.7 ± 1.5 | 0.0824 |
| PPD (mm)3 | 2.7 ± 0.6 | 2.9 ± 0.4 | 3.1 ± 0.9 | 0.2437 |
| BOP (%)1 | 49.3 ± 18.1 | 57.4 ± 10.2 | 52.5 ± 12.6 | 0.0850 |
| Plaque accumulation (%)3 | 54.5 ± 18.8 | 58.6 ± 18.8 | 56.1 ± 9.4 | 0.5256 |
1
ANOVA (p<0.05);
2
Fisher's exact test (p<0.05);
3
Kruskal Wallis test (p<0.05).
CAL: Clinical attachment level; PPD: Probing pocket depth; BOP: Bleeding on probing.